Determination of hydrochlorothiazide and irbesartan in pharmaceuticals by fourth-order UV derivative spectrophotometry

Farmaco

Volumn 60, Issue 8, 2005, Pages 665-670

  Vetuschi, C ^a   Giannandrea, A ^a   Carlucci, G ^b   Mazzeo, P ^c  

^a UNIVERSITY OF BARI   (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

^c UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

Antihypertensive analysis; Derivative spectrophotometry; Hydrochlorothiazide; Irbesartan; Multiple linear regression

Indexed keywords

ALCOHOL; HYDROCHLOROTHIAZIDE; HYDROCHLOROTHIAZIDE PLUS IRBESARTAN; IRBESARTAN;

ARTICLE; CONCENTRATION (PARAMETERS); LINEAR REGRESSION ANALYSIS; SPECTROPHOTOMETRY; ULTRAVIOLET RADIATION;

BIPHENYL COMPOUNDS; HYDROCHLOROTHIAZIDE; MOLECULAR STRUCTURE; PHARMACEUTICAL PREPARATIONS; SPECTROPHOTOMETRY, ULTRAVIOLET; TETRAZOLES;

EID: 23944433440     PISSN: 0014827X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.farmac.2005.04.013     Document Type: Article

References (40)

1. C. Vetuschi, and A. Giannandrea Anti-beer evaluation of Hydrochlorothiazide and Losartan by UV derivative spectrophotometry Anal. Lett. 36 2003 1051 1064
2. C. Cazaubon, J. Gougat, F. Bousquet, P. Guiraudou, R. Gayraud, C. Lacour, A. Roccon, G. Galindo, G. Barthelemy, and B. Gautret Pharmacological characterization of SR 47436, a new nonpeptide AT1 subtype angiotensin II receptor antagonist J. Pharmacol. Exp. Ther. 265 1993 826 834
3. J.V. Duncia, D.J. Carini, A.T. Chiu, A.L. Johnson, W.A. Price, P.C. Wong, R.R. Wexler, and P.B.M.W.M. Timmermans The discovery of DuP 753, a potent, orally active nonpeptide angiotensin II receptor antagonist Med. Res. Rev. 12 1992 149 191
4. P.B.M.W.M. Timmermans, P.C. Wong, A.T. Chiu, W.F. Herblin, P. Benfield, D.J. Carini, R.J. Lee, R.R. Wexler, J.A. Saye, and R.D. Smith Angiotensin II receptors and angiotensin II receptor antagonists Pharmacol. Rev. 45 1993 205 251
5. P.C. Wong, W.A. Price, A.T. Chiu, J.V. Duncia, D.J. Carini, R.R. Wexler, A.L. Johnson, and P.B.M.W.M. Timmermans Nonpeptide angiotensin II receptor antagonists. XI. Pharmacology of EXP3174: an active metabolite of DuP 753, an orally active antihypertensive agent J. Pharm. Exp. Ther. 255 1990 211 217
6. R.A. Stearns, R.R. Miller, G.A. Doss, P.K. Chakravarty, A. Rosegay, G.J. Gatto, and S.H. Chiu The metabolism of DuP 753, a nonpeptide angiotensin II receptor antagonist, by rat, monkey, and human liver slices Drug Metab. Disp. 20 1992 281 287
7. J.Y.-K. Hsieh, C. Lin, B.K. Matuszewski, and M.R. Dobrinska Fully automated methods for the determination of hydrochlorothiazide in human plasma and urine J. Pharm. Biomed. Anal. 12 1994 1555 1562
8. E. Cagigal, L. Gonzáles, R.M. Alonso, and R.M. Jiḿnes pKa determination of angiotensin II receptor antagonists (ARA II) by spectrofluorimetry J. Pharm. Biomed. Anal. 26 2001 477 486
9. L. Gonzales, R.M. Alonso, and R.M. Jimenez A high-performance liquid chromatographic method for screening angiotensin II receptor antagonists in human urine Chromatographia 52 2000 735 740
10. S. Hillaert, and W. Van den Bossche Simultaneous determination of hydrochlorothiazide and several angiotensin-II-receptor antagonists by capillary electrophoresis J. Pharm. Biomed. Anal. 31 2003 329 339
11. T.J. Chando, D.W. Everett, A.D. Kahle, A.M. Starrett, N. Vachharajani, W.C. Shyu, K.J. Kripalani, and R.H. Barbhaiya Biotransformation of irbesartan in man Drug Metab. Dispos. 26 1998 408 417
12. S.Y. Chang, D.B. Whigan, N.N. Vachharajani, and R. Patel High-performance liquid chromatographic assay for the quantitation of irbesartan (SR 47436/BMS-186295) in human plasma and urine J. Chromatogr. B702 1997 149 155
13. J. Li, Q. Wu, and L. Wang Assay of irbesartan tablets by HPLC Yaowu Fenxi Zazhi 21 2001 249 250
14. R.T. Sane, M. Francis, and S. Pawar Determination of irbesartan in pharmaceutical dosage forms by HPTLC Indian Drugs. 39 2002 32 35
15. M.A. Ghandour, E.A. Kasim, M.T. El-Haty, and M.M. Ahmed Cathodic stripping voltammetry of the antihypertensive drug captopril in both aqueous and biological media Anal. Lett. 35 2002 239 256
16. J.A. Prieto, R.M. Alonso, and R.M. Jimenez Determination of the angiotensin-converting enzyme inhibitor quinapril and its metabolite quinaprilat in pharmaceuticals and urine by capillary zone electrophoresis and solid-phase extraction Electrophoresis 23 2002 102 109
17. S. Hillaert, and W. Van den Bossche Optimisation and validation of a capillary zone electrophoretic method for the analysis of several angiotensin-II-receptor antagonists J. Chromatogr. A 979 2002 323 333
18. J.A. Prieto, U. Akesolo, R.M. Jimenez, and R.M. Alonso Capillary zone electrophoresis applied to the determination of the angiotensin-converting enzyme inhibitor cilazapril and its active metabolite in pharmaceuticals and urine J. Chromatogr. A. 916 2001 279 288
19. A.A. Al-Majed, F. Belal, and A.A. Al-Warthan Spectrophotometric determination of ramipril (a novel ACE inhibitor) in dosage forms Spectrosc. Lett. 34 2001 211 220
20. K. Kargosha, and A.H.M. Sarrafi Spectrophotometric simultaneous determination of triamterene and hydrochlorothiazide in Triamterene-H tablets by multivariate calibration methods J. Pharm. Biomed. Anal. 26 2001 273 279
21. A. El-Gindy, A. Ashour, L. Abdel-Fattah, and M.M. Shabana Spectrophotometric and HPTLC-densitometric determination of lisinopril and hydrochlorothiazide in binary mixtures J. Pharm. Biomed. Anal. 25 2001 923 931
22. N. Erk Spectrophotometric analysis of valsartan and hydrochlorothiazide Anal. Lett. 35 2002 283 302
23. A. El-Gindy, A. Ashour, L. Abdel-Fattah, and M.M. Shabana Spectrophotometric determination of benazepril hydrochloride and hydrochlorothiazide in binary mixture using second derivative, second derivative of the ratio spectra and chemometric methods J. Pharm. Biomed. Anal. 25 2001 299 307
24. N. Erk Analysis of binary mixtures of losartan potassium and hydrochlorothiazide by using high performance liquid chromatography, ratio derivative spectrophotometric and compensation technique J. Pharm. Biomed. Anal. 24 2001 603 611
25. M.L. Luis, J.M.G. Fraga, F. Jiḿnez, A.I. Jiḿnez, and J.J. Arias Simultaneous spectrophotometric determination of diuretics by using multivariate calibration methods Talanta 53 2001 761 770
26. S. Saõlyk, O. Saõyrly, S. Atmaca, and L. Ersoy Simultaneous determination of fosinopril and hydrochlorothiazide in tablets by derivative spectrophotometric and high-performance liquid Chromatographic methods Anal. Chim. Acta 427 2001 253 257
27. R.A.S. Lapa, J.L.F.C. Lima, and J.L.M. Santos Dual-stopped-flow spectrophotometric determination of amiloride hydrochloride in a multicommutated flow system Anal. Chim. Acta 407 2001 225 231
28. A. El-Gindy, A. Ashour, L. Abdel-Fattah, and M.M. Shabana Application of LC and HPTLC-densitometry for the simultaneous determination of benazepril hydrochloride and hydrochlorothiazide J. Pharm. Biomed. Anal. 25 2001 171 179
29. N. Erk Simultaneous determination of irbesartan and hydrochlorothiazide in human plasma by liquid chromatography J. Chromatogr. B 784 2003 195 201
30. L. Manna, L. Valvo, and S. Alimonti A liquid chromatographic ion-pairing method for simultaneous determination of benazepril hydrochloride, fosinopril sodium, ramipril and hydrochlorothiazide in pharmaceutical formulations Chromatographia 53 2001 S271 S275
31. O. Atay, U. Tamer, and D. Arykan Determination of cilazapril and hydrochlorothiazide in pharmaceuticals by high performance liquid chromatography Anal. Lett. 34 2001 1153 1161
32. E. Banoglu, Y. Özkan, and O. Atay Dissolution tests of benazepril-HCl and hydrochlorothiazide in commercial tablets: comparison of spectroscopic and high performance liquid chromatography methods Farmaco 55 2000 477 483
33. G. Carlucci, V. Di Carlo, and P. Mazzeo Simultaneous determination of valsartan and hydrochlorothiazide in tablets by high-performance liquid chromatography Anal. Lett. 33 2000 2491 2500
34. G. Carlucci, G. Palombo, P. Mazzeo, and M. Giovanna Quaglia Simultaneous determination of losartan and hydrochlorothiazide in tablets by high-performance liquid chromatography J. Pharm. Biomed. Anal. 23 2000 185 189
35. A.P. Argekar, and J.G. Sawant A gradient reversed phase high performance liquid chromatography method for simultaneous determination of hydrochlorothiazide (HCT) and losartan potassium (LOS) from tablets Anal. Lett. 33 2000 869 880
36. F. Belal, I.A. Al-Zaagi, E.A. Gadkariem, and M.A. Abounassif A stability-indicating LC method for the simultaneous determination of ramipril and hydrochlorothiazide in dosage forms J. Pharm. Biomed. Anal. 24 2001 335 342
37. S.T. Hassib, Z.A. El-Sherif, R.I. El-Bagary, and N.F. Youssef Reversed-phase high performance liquid chromatographic and thin layer chromatographic methods for the simultaneous determination of benazepril hydrochloride and hydrochlorothiazide in Cibadrex Tablets Anal. Lett. 33 2000 3225 3237
38. I. Albero, V. Ródenas, G. Soledad, and C. Sánchez- Pedreño Determination of irbesartan in the presence of hydrochlorothiazide by derivative spectrophotometry J. Pharm. Biomed. Anal. 29 2002 299 305
39. J. Joseph-Charles, S. Brault, C. Boyer, M.-H. Langlois, L. Cabrero, and J.-P. Dubost Simultaneous determination of irbesartan and hydrochlorothiazide in tablets by derivative spectrophotometry Anal. Lett. 36 2003 2485 2495
40. N. Erk Three new spectrophotometric methods applied to the simultaneous determination of hydrochlorothiazide and irbesartan Pharmazie 58 2003 543 548